Neurochemical and behavioural profiles of five dopamine analogues

@article{Sumners2004NeurochemicalAB,
  title={Neurochemical and behavioural profiles of five dopamine analogues},
  author={C. Sumners and D. Dijkstra and J. Vries and A. Horn},
  journal={Naunyn-Schmiedeberg's Archives of Pharmacology},
  year={2004},
  volume={316},
  pages={304-310}
}
SummaryThe dopaminergic actions of five hydroxylated dopamine analogues have been examined for: i) Ability to induce stereotypy, ii) Effects upon dopamine metabolism, iii) Ability to antagonise the rise in striatal dopamine caused by gammabutyrolactone. With the exception of the resorcinol derivative 2-(3,5-dihydroxyphenyl)-N,N-dipropylethylamine, all of the compounds tested exhibited dopamine-like actions, and similarities were found in the induction of stereotypy and in the reduction of… Expand
4 Citations
Optical Control of Dopamine Receptors Using a Photoswitchable Tethered Inverse Agonist.
TLDR
The results indicate that DARs can be chemically engineered for selective remote control by light and provide a template for precision control of Family A GPCRs. Expand
Synthesis and radioreceptor binding activity of N-0437, a new, extremely potent and selective D2 dopamine receptor agonist
TLDR
The results of a radioreceptor binding assay using a homogenate of porcine anterior pituitary as a tissue source for D2 dopamine receptors and3H-spiperone as radioligand demonstrate that this compound is one of the most potent compounds so far evaluated in this test system. Expand
The 2-aminotetralin system as a structural base for new dopamine- and melatonin-receptor agents
The research described in this thesis is divided into two parts. Part I (chapters 1-3) deals with the development of a novel 2-aminotetralin as a mixed dopamine Dl/D2-receptor agonist, whereas partExpand
Cell specific photoswitchable agonist for reversible control of endogenous dopamine receptors
TLDR
This work develops a photo-pharmacological strategy using a Membrane anchored Photoswitchable orthogonal remotely tethered agonist for the Dopamine receptor (MP-D) that combines ligand and cell type-specificity with temporally precise and reversible activation of D1R to control specific aspects of movement. Expand

References

SHOWING 1-10 OF 35 REFERENCES
Effect of dihydroxy-2-aminotetralin derivatives on dopamine metabolism in the rat striatum
TLDR
The results corroborate reported behavioural data, and the relative potencies of the alkylated derivatives in this test system for dopaminergic activity are in agreement with those based on stereotyped behaviour. Expand
Agonist-antagonist interaction on dopamine receptors in brain, as reflected in the rates of tyrosine and tryptophan hydroxylation
TLDR
The interaction between apomorphine and haloperidol with respect to dopa formation appears to be largely explicable on the assumption of a competition between an agonist and an antagonist for dopaminergic receptors. Expand
Pivaloyl esters of N,N-dialkylated dopamine congeners. Central dopamine-receptor stimulating activity.
TLDR
The relationship was found for the corresponding phenols, N,N-dipropyldopamine (3) and 2-(3-hydroxyphenyl)-N,N -dipropylethylamine (7), although both were more active than their pivaloyl esters. Expand
Evidence for dopamine receptor stimulation by apomorphine
TLDR
Supporting evidence for apomorphine acts on the dopamine receptors whereas amphetamine acts by releasing dopamine is given by further functional, biochemical and histochemical studies. Expand
Activity of two new potent dopaminergic agonists at the striatal and anterior pituitary levels
TLDR
The present data indicate that these two new drugs have potent dopaminergic activity at the striatal and anterior pituitary levels and therefore have a potential therapeutic activity for the treatment of Parkinson's disease and prolactin-secreting adenomas. Expand
EFFECT OF α-METHYLDOPA ON THE METABOLISM OF DOPAMINE IN THE STRIATUM OF THE RAT
The mode of action of α-methyldopa in depleting dopamine (DA) levels in the striatum was studied. After the administration of α-methyldopa, the maximum accumulation of α-methyldopamine (α-MDA)Expand
Inhibition by dopamine agonists of dopamine accumulation following γ-hydroxybutyrate treatment
Abstract The increase in the dopamine (DA) concentration of rat (whole) brain induced by γ-hydroxybutyrate was inhibited by the reputed dopamine agonists apomorphine, apocodeine,Expand
A new dopaminergic prodrug
TLDR
An improved, simplified synthesis of ADTN is developed consisting of four steps and it is described how the passage of the drug into the brain is effected, throwing new light on the in vivo action of this drug. Expand
Brain receptors for antipsychotic drugs and dopamine: direct binding assays.
TLDR
Various antipsychotic drugs inhibited this stereospecific component in both the dopamine and haloperidol assays, and these inhibitory potencies correlated with the clinical doses used for controlling schizophrenia. Expand
Dopaminergic neurons: drug-induced antagonism of the increase in tyrosine hydroxylase activity produced by cessation of impulse flow.
  • J. Walters, R. Roth
  • Chemistry, Medicine
  • The Journal of pharmacology and experimental therapeutics
  • 1974
TLDR
It is suggested that inhibition of firing in the nigro-neostriatal dopamine system is followed by an immediate and rapid increase in the rate of dopamine synthesis in the neostriatum, and the increase in synthesis appears to take place at the tyrosine hydroxylase step. Expand
...
1
2
3
4
...